|
- 2017
肿瘤转移抑制基因-1在食管鳞癌组织及食管癌EC109细胞中的表达及意义
|
Abstract:
摘要:目的 探讨肿瘤转移抑制基因-1(TMSG-1)在食管鳞癌(ESCC)组织及食管癌EC109细胞中的表达及意义。方法 采用SP免疫组织化学染色法检测136例ESCC及37例正常食管黏膜组织中TMSG-1蛋白的表达情况,分析TMSG-1与ESCC患者临床病理指标的关系;培养人食管癌EC109细胞并用常用化疗药物顺铂(CDDP)干预,同时设对照组,采用MTT法检测细胞增殖抑制率,半定量RT-PCR法检测细胞TMSG-1的表达情况。结果 TMSG-1在ESCC和正常食管黏膜的阳性率分别为52.2%(71/136)、94.6%(35/37),差异具有统计学意义(P<0.05)。TMSG-1的异常表达与ESCC组织学分级、患者的TNM分期、淋巴结转移情况相关。顺铂干预组EC109细胞的增殖抑制率较对照组显著增高,差异具有统计学意义(P<0.01)。RT-PCR结果显示,干预组EC109 细胞TMSG-1的mRNA表达明显高于对照组(P<0.01)。结论 TMSG-1的异常表达与ESCC的发展及转移相关,可作为较为理想的肿瘤标志物辅助诊断并指导临床治疗。
ABSTRACT: Objective To study the expression and significance of tumor metastasis suppressor gene-1(TMSG-1) in esophageal squamous cell carcinoma (ESCC) and EC109 cells. Methods Immunohistochemistry S-P method was used to examine the expression of TMSG-1 protein in 136 cases of ESCC and 37 cases of normal esophageal mucosa. We analyzed the relationship between TMSG-1 and clinicopathological data of ESCC patients. EC109 cells were treated with 3μg/mL of cisplatin (CDDP) in vitro for 24h (the intervention group) and the control group was set up at the same time. The proliferation-inhibitory capability was analyzed with MTT assay. RT-PCR was used to examine the expression of TMSG-1 in the intervention group and the control group. Results The positive rate of TMSG-1 in ESCC and normal esophageal mucosa was 52.2%(71/136) and 94.6%(35/37), respectively. The expression of TMSG-1 in ESCC was significantly lower than that in normal esophageal mucosa (P<0.05). The expression of TMSG-1 was related to TNM stage, differentiation degree and lymph node metastasis (P<0.05). After EC 109 cells were treated with CDDP for 24h, the proliferation inhibition rate was increased significantly compared with the control group (P<0.01). RT-PCR results showed that the expression of TMSG-1 in the cells of the intervention group was significantly higher than that in the control group (P<0.01). Conclusion The abnormal expression of TMSG-1 may play a role in the development and metastasis of ESCC. Examination of TMSG-1 may be useful for making diagnosis and guiding clinical therapy of ESCC
[1] | VENKAYYA R, LAM M, WILLKOM M, et al. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyper-responsiveness through direct effects on resident airway cells[J]. Am J Respir Cell Mol Biol, 2002, 26(2):202-208. |
[2] | HAMADA N, MAEYAMA T, KAWAGUCHI T, et al. The role of high mobility group box1 in pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2008, 39(4):440-447. |
[3] | 付亮,蔡绍曦,赵海金,等. N-乙酰半胱氨酸对哮喘小鼠肺组织HMGB1、RAGE表达的影响[J]. 南方医科大学学报, 2008, 28(5):692-695. |
[4] | 谭小玉,侯长春,陈俊健,等. IL-1β诱导支气管上皮细胞高迁移率族蛋白1主动释放[J].重庆医学, 2015, 44(2):151-154. |
[5] | GOLDSTEIN RS, BRUCHFELD A, YANG L, et al. Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis[J]. Mol Med, 2007, 13(3-4):210-215. |
[6] | 刘勇,黄亮,杨继斌,等. 不同潮气量机械通气对复苏犬支气管灌洗液中TOLL样受体4变化的影响[J]. 中国急救医学, 2012, 32(8):704-708. |
[7] | STRAUB C, MIDORO-HORIUTI T, GOLDBLUM R. Elucidating the role of high mobility group box1 (HMGB1) cytokine in a murine model of allergic asthma[J]. J Allergy Clin Immu, 2010, 125(2):AB108. |
[8] | YANG Q, LIU X, YAO Z, et al. Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice[J]. J Surg Res, 2014, 186(1):310-317. |
[9] | MUSUMECI D, ROVIELLO GN, MONTESARCHIO D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies[J]. Pharmacol Ther, 2014, 141(3):347-357. |
[10] | HANSDOTTIR S,MONICK MM.Vitamin D effects on lung immunity and respiratory diseases[J].Vitam Horm, 2011, 86:217-237. |
[11] | MAYUZUMI H, OHKI Y, TOKUYAMA K, et al. Age-related difference in the persistency of allergic airway inflammation and bronchial hyperresponsiveness in a murine model of asthma[J]. Int Arch Allergy Immunol, 2007, 143(4):255-262. |
[12] | LEE CC, LAI YT, CHANG HT, et al. Inhibition of high-mobility group box1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma[J]. Biochem Pharmacol, 2013, 86(7):940-949. |
[13] | BARKAUSKAITE V, EK M, POPOVIC K, et al. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus[J]. Lupus, 2007, 16(10):794-802. |
[14] | TEMELKOVSKI J, HOGAN SP, SHEPHERD DP, et al. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen[J]. Thorax, 1998, 53(10):849-856. |
[15] | HUANG TJ, MACARY PA, EYNOTT P, et al. Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-γ[J]. J Immunol, 2001, 166(1):207-226. |
[16] | 齐?b禄,杨敬平,银雪,等. 外周血中 TLR4、TIRAP 表达与脓毒症相关性研究[J]. 临床肺科杂志, 2015, 20(1):19-22. |
[17] | WU J, KOBAYASHI M, SOUSA EA, et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge[J]. Mol Cell Proteomics, 2005, 4(9):1251-1264. |
[18] | 贾晨虹,王建,董力,等. 糖皮质激素对哮喘患者外周血单核细胞 TLR4和相关炎症因子表达的影响[J]. 实用临床医药杂志, 2015, 19(23):41-43. |
[19] | CHEN WJ, HOU XJ, YANG SF, et al. Effect of vitamin D supplementation during pregnancy on the Th1/Th2 cell balance of rat offspring[J]. Pharmazie, 2014, 69(5):385-390. |
[20] | BAEKE F, KORF H, OVERBERGH L, et al. The vitamin D analog, TX527, promotes a human CD4+CD25highCDl2710w regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation[J]. J Immunol, 2011, 186(1):132-142. |
[21] | DOGRU M, KIRMIZIBEKMEZ H, YESILTEPE MUTLU RG, et al. Clinical effects of vitamin D in children with asthma[J]. Int Arch Allergy Immunol, 2014, 164(4):319-325. |
[22] | 李如霞,侯进飞,周瑾思,等. 1,25-二羟基维生素D3对尘螨引起的P815肥大细胞TLR4表达和IL-4分泌影响的初步研究[J]. 中华微生物学和免疫学杂志, 2015, 35(3):188-193. |
[23] | 王学亮,周传麟,王丽娜. 维生素D对支气管哮喘患者Th1/Th2平衡的调节作用及IL-17的影响[J]. 国际呼吸杂志, 2015, 35(1):9-11. |
[24] | SADEGHI K, WESSNER B, LAGGNER U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns[J]. Eur J Immunol, 2006, 36(2):361-370. |
[25] | ENTEZARI M, WEISS DJ, SITAPARA R, et al. Inhibition of high-mobility group box1 protein (HMGBl) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis[J]. Mol Med, 2012, 18(3):477-485. |
[26] | SUNDEN-CULLBERG J, NORRBY-TEGLUND A, ROUHIAINEN A, et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock[J]. Crit Care Med, 2005, 33(3):564-573. |
[27] | MATHEU V, B?FCK O, MONDOC E, et al. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease[J]. J Allergy Clin Immunol, 2003, 112(3):585-592. |